解析素E1对人类血小板的抗聚合潜力
Patrycja Szymańska1, Bogusława Luzak1, Katarzyna Miłowska2
1Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Molecules (Basel, Switzerland)
|July 29, 2023
概括
作为omega-3脂肪酸代谢物之一的Resolvin E1,可以通过原体受体抑制血小板聚合和激活. 这一发现表明,欧米茄-3PUFA在预防心血管疾病方面有潜在的应用.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 欧米茄-3多不和脂肪酸 (PUFA) 具有已知的抗血小板作用.
- 通过原体受体对血小板功能有什么特殊影响,目前尚不清楚.
研究的目的:
- 为了研究resolvin E1对原诱导的血小板聚合,激活和反应性的作用.
- 探索Resolvin E1对血小板膜流动性和结构的影响.
- 为了阐明解决E1的抗聚合性质背后的分子机制.
主要方法:
- 在富含血小板的血,全血和分离的血小板中评估原诱导的血小板聚合.
- 在刺激的血小板上测量P-选择因暴露.
- 评估血小板膜流动性和结构.
主要成果:
- 雷索尔文E1显著降低了富含血小板的血和分离的血小板中的原诱导的血小板聚合,但不是在全血中.
- 瑞索尔E1显著降低了原刺激血小板上的P-选择因暴露.
- 瑞索尔E1维持了血小板膜结构,而没有增加流动性.
结论:
- 瑞索尔E1通过抑制原诱导的聚合和激活,表现出抗血小板作用.
- 需要进一步的研究来澄清膜流动性和原受体的作用.
- 像resolvin E1这样的欧米茄-3 PUFA代谢物代表了开发用于预防心血管疾病的新型抗血小板治疗的有希望的途径.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563
01:22Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
01:18Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
01:16Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
01:17Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753